|Day Low/High||56.48 / 56.49|
|52 Wk Low/High||18.41 / 38.49|
These stocks should be part of a strong first-quarter earnings season.
These two large-cap drug giants should be core parts of any well-diversified portfolio.
Allergan shares are rising on news the company is purchasing medical tech company Zeltiq Aesthetics for roughly $2.5 billion.
Stocks trade above record highs set on Friday as good vibes over the potential Trump tax reform plan are sustained over the weekend.
Based on the Allergan conference call (more on this tomorrow!), I am raising my year-end 2017 price target once again. Originally set at $260 and then raised to a target of $290, my new price target will be above $300 a share. I am working on my...
3 Top Off-the-Radar Consumer Stocks for 2017: Zeltiq Aesthetics, Yelp and LendingTree.
Medical technology companies are hot and not even climbing price-to-earnings multiples will slow down the likes of Hologic, Zimmer Biomet, Zeltiq and NuVasive.
The trend is global, and the investment opportunities extend beyond health-care companies.